OPTHEA US, INCOpthea LTD • September 29th, 2022 • Biological products, (no disgnostic substances) • California
(b)Annual Bonus. You will be eligible for an annual discretionary performance bonus with a target amount of forty percent (40%) of your base salary, less payroll deductions and withholdings. The amount of this bonus will be determined in the discretion of the Company and based, in part, on your performance and the performance of the Company during the calendar year, as well as any other criteria the Company deems relevant. The Company will pay you this annual bonus, if any, no later than 15th September of the year occurring following the close of the fiscal year ending the immediately preceding June 30. In the event of a Qualifying Termination, your bonus will be prorated based on the number of days you were employed by the Company during the fiscal year..
OPTHEA US INC.Opthea LTD • September 29th, 2022 • Biological products, (no disgnostic substances)
On behalf of OPTHEA US, INC. (the"Company"), I am pleased to offer you employment at the Company on the terms set forth in this offer letter agreement (the "Agreement''). As discussed, the terms of this Agreement. govern with respect to your employment, which is anticipated to start on January 1, 2022 (such actual date of your commencement of employment shall be referred to herein as the "Start Date").
Development Funding Agreement by and between Opthea Limited and Ocelot SPV LPDevelopment Funding Agreement • September 29th, 2022 • Opthea LTD • Biological products, (no disgnostic substances) • New York
This Development Funding Agreement (“Agreement”), dated August 12, 2022 (the “Effective Date”), is by and between Opthea Limited ACN 006 340 567, a company incorporated under the laws of Victoria, Australia (“Opthea”), and Ocelot SPV LP, a Delaware limited partnership (“Investor”). Each of Investor and Opthea may be referred to herein individually as a “Party” and collectively as the “Parties”.
